Page 10 - Hal Barron News Today

FDA on Thursday announced it launched a new public dashboard that lists drugs with an approved Risk Evaluation and Mitigation Strategy.

In a setback for chief exec Emma Walmsley, veteran drug developer Hal Barron (pictured) will step down as chief scientific officer in August.

Emma Walmsley could not have done more to woo Hal Barron to Glaxo. He was offered a pay package worth more than that of the chief executive.

Teva Pharmaceutical agreed to pay $420 million to settle shareholder lawsuits alleging it hid a scheme to fix generic drug prices.

GlaxoSmithKline's loss of top scientist to a de-ageing start-up makes pharma giant look seriously vulnerable

GlaxoSmithKlines chief scientific officer Hal Barron, left, is leaving to run a new privately-owned biotech start-up backed by Jeff Bezos that hopes to reverse the ageing process.

The backers of the company where scientist Hal Barron is set to become chief executive and co-chairman reportedly include Amazon founder Jeff Bezos and Russian... 20.01.2022, Sputnik International

FTSE 100 Falls as UK Inflation Soars 0853 GMT - The FTSE 100 falls 0.1% to 7558 points as investors react to data showing U.K. inflation accelerated to its highest level in nearly 30 years in...

SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep b...

LONDON – GlaxoSmithKline said on Wednesday